Drug
Mp0112
Mp0112: highest development phase Phase 1, developed by Molecular Partners. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Molecular Partners
Trials
| Drug | Phase | Indication |
|---|---|---|
| MP0112 NCT01042678 | Phase 1 | Diabetic Macular Edema |
| MP0112 NCT01086761 | Phase 1 | Wet Age-Related Macular Degeneration |
Latest
No recent events.
Follow Mp0112 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.